Resident Evil Wiki
Resident Evil Wiki
m (clean up)
m (→‎top: AWB edit)
 
(10 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
{{articletype|perry}}
 
{{articletype|perry}}
   
'''''Valifin''''' was an experimental [[Umbrella Corporation (Perry)|Umbrella]] drug undergoing clinical trials in [[1998]]. It was designed to combat heart disease but had a side effect of renal failure.<ref>Perry, ''[[Resident Evil: Zero Hour|Zero Hour]]'', Chapter One.</ref>
+
'''Valifin''' was an experimental [[Umbrella Corporation (Perry)|Umbrella]] drug undergoing clinical trials in early [[1998]]. It was designed to combat [[Wikipedia:Heart disease|heart disease]] but had a side effect of [[Wikipedia:Kidney failure|kidney failure]]. This was discovered too late and Umbrella was forced to pay off the family of a girl undergoing the trial.<ref>Perry, ''[[Resident Evil: Zero Hour|Zero Hour]]'', Chapter One.</ref>
   
 
==Sources==
 
==Sources==
Line 7: Line 7:
   
 
{{Fictional products}}
 
{{Fictional products}}
  +
{{Perry lore}}
  +
[[es:Valifin]]
   
[[Category:Umbrella Corporation]]
+
[[Category:Perry lore]]
  +
[[Category:Umbrella products]]
{{stub}}
 

Latest revision as of 22:55, 14 May 2020

Perry universe
(Covers information from the S.D. Perry novels)

Valifin was an experimental Umbrella drug undergoing clinical trials in early 1998. It was designed to combat heart disease but had a side effect of kidney failure. This was discovered too late and Umbrella was forced to pay off the family of a girl undergoing the trial.[1]

Sources[]

  1. Perry, Zero Hour, Chapter One.